RNAi (Ribonucleic Acid Interference) is an RNA-dependent gene silencing process that occurs in live cells to keep a check on the active genes. The major classes of RNAi are micro RNA and small interfering RNA. It is a valuable research tool to selectively induce suppression of genes of interest. RNAi is said to replace the existing recombinant technology in the field of drug discovery and therapeutics.
RNA Interference (RNAi) market is segmented by products, applications, delivery modes, and end users. RNA Interference (RNAi) market by products is segmented into design, monitoring/optimizing, and libraries. Based on the libraries, the market is divided into humans, mice, and rats. On the basis of applications, the market is segmented into research and development, therapeutics, drug discovery and development, and agriculture. Based on delivery mode, this market is segmented into vector based, transfection reagents, and electroporation. On the basis of end users, the market is divided into pharmaceutical companies, agriculture based industries, and biotechnology companies. Based on geographies, the market is divided into North America, Europe, Asia, and Rest of World (RoW).
The major factors driving growth of this market are increase in RNA therapeutic development and requirement of lower therapeutic dosages. Inefficiency in RNA drug delivery system is the major restraining factor to this market. Agriculture is an emerging field to use RNAi technology for crop improvement.
Some of the key players in this market are Qiagen N. V., Invitrogen Corporation, Ambion, Inc., Tekmira Pharmaceuticals Corporation, and Merck & Co., Inc.
Decision Databases is involved in providing research reports and company profiles in the global RNA Interference market in terms of revenue and output/volume. Market drivers, opportunities and restraints are thoroughly studied which influences the market. This study is further utilized for the overall analysis of the market. The RNA Interference market is segmented based on the global applications, geographic presence, by products and ingredients. We offer an inclusive category-specific market outlook. We provide access to a comprehensive collection of companies in the industry. The companies can strategize and execute business operations through our competitor analysis. Find the global industry analysis, market size, share, growth, and trends information in our RNA Interference profiles.
The Global Tigecycline Market report is a recent research added by DecisionDatabases.com, offers critical insight into the Market dynamic. This report read more..
The Global Risperidone Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost read more..
The Global Caffeine Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost structure, read more..
The Global Rabies Vaccine Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost read more..
The United States Parkinsons Disease Drug market research report is the study prepared by analysts, which contain a detailed analysis of drivers, read more..
The Global Radiopharmaceuticals market report is a recent research added by DecisionDatabases.com, offers critical insight into the Market dynamic. This read more..
Neurorehabilitation system is as innovative technological solution to monitor and review the activity of nervous systems. It is a relatively new method read more..
The global molecular biology kits and reagents market is expected to grow at a CAGR of ~7% from 2013 to 2018. A number of factors such as rise in read more..
The global high acuity care information systems market is expected to grow at a CAGR of ~4% from 2013 to 2018. A number of factors such as growing focus read more..
The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013. A number of factors such as increasing bone related read more..